Tavin 300mg tablet tablet consists of the active substance called Tenofovir Disoproxil Fumarate, which belongs to the class of antiretroviral or antiviral medicine. This medicine treats HIV (human immunodeficiency virus) and HBV (hepatitis B virus) infections. It is a nucleotide reverse transcriptase inhibitor (NRTI) and works by inhibiting the enzymes (HIV reverse transcriptase; hepatitis B DNA polymerase) that are important for virus replication. It should always take in combination with other medicines to treat HIV infection. This tablet is suitable for the adult and adolescents aged from 12 to 18 years. For HIV, this medicine is given to adolescents who have already been medicated with other HIV medicines which are no longer fully effective due to resistance or have caused side effects. This tablet is not been studied in patients over 65 years of age. Do not consume this drug if you have experienced hypersensitivity reactions to Tenofovir disoproxil fumarate or any of its ingredients. During the Tavin 300mg tablet tablet treatment, your doctor may periodically monitor your blood counts, bone mineral density, liver and kidney parameters to prevent serious complications. Report to your doctor if you have had a history of heart failure, pancreatitis, bone disease (osteonecrosis - the death of bone tissue), fractures, liver (chronic hepatitis B or C), or kidney problems.

Tafero EM tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body. Do not take Tafero EM tablet if you are allergic to Emtricitabine/ tenofovir alafenamide or any of the other ingredients. Get tested for HIV infection regularly while using this medicine. Do not miss any doses of this medicine or stop taking it. Missing doses may increase your risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Inform your physician if you have liver problems or suffer from liver disease, including hepatitis, kidney problems, and bone problems. Do not give this medicine to children aged 11 years or under.

ABIROGEN 250 whose content is Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. ABIROGEN 250 whose content is Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that... Abiraterone Acetate is an oral medication primarily used in the treatment of prostate cancer. It’s usually prescribed under brand names like Zytiga or Yonsa, often along with prednisone. 🔬 What It Is Type: Hormone therapy (androgen biosynthesis inhibitor) Class: CYP17 inhibitor Form: Oral tablets or pills Used For: Metastatic castration-resistant prostate cancer (mCRPC) or metastatic high-risk castration-sensitive prostate cancer (mCSPC) 🔹 What It’s Used For Abiraterone Acetate is used to treat advanced prostate cancer, especially in men whose disease: Has spread to other parts of the body (metastatic) No longer responds to standard hormone therapy (castration-resistant) Is high-risk but still sensitive to androgen deprivation ⚙️ How It Works Abiraterone blocks an enzyme called CYP17A1, which is essential for producing androgens (male hormones) such as testosterone. Since prostate cancer cells grow in response to these hormones, reducing their levels can slow or stop tumor growth. 💊 Common Dosing 1,000 mg once daily (usually 4 x 250 mg tablets) Taken on an empty stomach Given with low-dose prednisone (typically 5–10 mg/day) to prevent side effects related to hormone imbalance